INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 425m ago
House PTR25m ago
SEC 13F24m ago
Robinhood Chain24m ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
BB
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$228K
991 sh
Jan 29, 2026Jan 29, 2026
Page 352 of 481
← PrevNext →
traded Jan 29, 2026
+0d
SEC Form 4

Evidence

15
PL
Phillips Ronald LEVP and CHRO
SYYSYSCO CORP
Open-market sale · 10b5-1 plan
SELL$454K
5,601 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$375K
2,784 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$501K
3,700 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$375K
2,785 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$501K
3,700 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

8
JD
Jedrzejek DavidSVP and General Counsel
LEVILEVI STRAUSS & CO
Open-market sale · 10b5-1 plan
SELL$152K
7,093 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

6
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Open-market sale · 10b5-1 plan
SELL$21K
25.0K sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$99K
8,268 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$63K
455 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$61K
445 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$95K
7,842 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$63K
455 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$61K
445 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$39K
280 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$39K
281 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

3
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$36K
3,090 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

2
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Open-market sale · 10b5-1 plan
SELL$22K
25.0K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

1
GR
Gallagher John RChief Operating Officer
TRUPTRUPANION, INC.
Open-market sale · 10b5-1 plan
SELL$14K
430 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

66
NE
Nelson Jeffrey EdwardChief Operating Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$135K
58.0K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

62
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$135K
58.0K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

62
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$124K
53.6K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

62
BD
Bharucha DavidChief Medical Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$135K
58.0K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
731 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
730 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,239 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,238 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

37
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$631K
6,209 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

37
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$691K
7,007 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

37
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$691K
7,007 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

37
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$631K
6,209 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.60M
25.5K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
NE
Nelson Jeffrey EdwardChief Operating Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$24K
12.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.84M
28.8K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$24K
12.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
BD
Bharucha DavidChief Medical Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$24K
12.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$22K
11.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

35
SC
Spencer CourtneyChief Experience Officer
LOBLive Oak Bancshares, Inc.
Open-market sale
SELL$378K
9,700 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

35
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$7,776
73 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

35
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
255 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence